Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/114725
DC FieldValueLanguage
dc.contributorDepartment of Health Technology and Informaticsen_US
dc.creatorGuo, Yen_US
dc.creatorLee, CLen_US
dc.creatorMeng, Yen_US
dc.creatorLi, Yen_US
dc.creatorWong, SCSen_US
dc.creatorLeung, HKMen_US
dc.creatorYeung, WSBen_US
dc.creatorCheung, KWen_US
dc.creatorZhang, Qen_US
dc.creatorChiu, PCNen_US
dc.date.accessioned2025-08-21T03:57:42Z-
dc.date.available2025-08-21T03:57:42Z-
dc.identifier.issn0143-4004en_US
dc.identifier.urihttp://hdl.handle.net/10397/114725-
dc.language.isoenen_US
dc.publisherElsevier Ltden_US
dc.subjectBiomarkeren_US
dc.subjectmiRNAen_US
dc.subjectPlacental complicationen_US
dc.subjectPlacental developmenten_US
dc.subjectTherapeutic targeten_US
dc.subjectTrophoblasten_US
dc.titleUnraveling the role of miRNAs in placental function : insights into trophoblast biology and pregnancy pathologyen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.doi10.1016/j.placenta.2025.08.327en_US
dcterms.abstractMicroRNAs (miRNAs) are pivotal regulators of placental development and function, orchestrating critical processes such as trophoblast proliferation, differentiation, invasion, and vascular remodeling. By modulating diverse signaling pathways, these small non-coding RNAs help ensure proper placental formation and optimal maternal-fetal nutrients and gases exchange. Dysregulated miRNA expressions can profoundly affect placental biology, leading to complications such as preeclampsia, fetal growth restriction, and recurrent pregnancy loss. Accumulating evidence implicates abnormal miRNA profiles in defective spiral artery remodeling and impaired trophoblast activity. Notably, circulating miRNAs exhibit high stability and tissue specificity, positioning them as promising noninvasive biomarkers for early detection of pregnancy complications. Recent preclinical studies highlight the therapeutic potential of miRNA-based modulators using mimics or inhibitors to restore normal placental function. However, challenges remain in optimizing placental-targeted delivery systems. Collectively, miRNAs are pivotal in placental health and disease, offering potential as biomarkers and therapeutic targets.en_US
dcterms.accessRightsembargoed accessen_US
dcterms.bibliographicCitationPlacenta, Available online 15 August 2025, In Press, Corrected Proof, https://doi.org/10.1016/j.placenta.2025.08.327en_US
dcterms.isPartOfPlacentaen_US
dcterms.issued2025-
dc.identifier.eissn1532-3102en_US
dc.description.validate202508 bcchen_US
dc.description.oaNot applicableen_US
dc.identifier.FolderNumbera3987-
dc.identifier.SubFormID51872-
dc.description.fundingSourceOthersen_US
dc.description.fundingTextThis work was supported by the Hong Kong Health and Medical Research Fund 09202056.en_US
dc.description.pubStatusEarly releaseen_US
dc.date.embargo0000-00-00 (to be updated)en_US
dc.description.oaCategoryGreen (AAM)en_US
Appears in Collections:Journal/Magazine Article
Open Access Information
Status embargoed access
Embargo End Date 0000-00-00 (to be updated)
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.